Postviral Platelet-Activating Anti-PF4 Disorder Responsive to High-Dose Intravenous Immunoglobulin
A 54-year-old man presented with diffuse bleeding and thrombosis and was initially considered to have immune thrombocytopenia and, later, disseminated intravascular coagulation. Ultimately, the condition was determined to be due to a platelet-activating antiplatelet factor 4 (anti-PF4) disorder, pre...
Saved in:
| Main Authors: | Min Woo Hwang, William B. Ershler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2024-06-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2024.0095 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complex therapy of patients with postviral syndrome and chronic fatigue syndrome
by: A. S. Karabaeva
Published: (2023-06-01) -
Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody–induced immunothrombosis
by: Jan Zlamal, et al.
Published: (2025-04-01) -
Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin
by: A. M. Nikolaeva, et al.
Published: (2023-02-01) -
Non-ST Elevation Myocardial Infraction after High Dose Intravenous Immunoglobulin Infusion
by: Meir Mizrahi, et al.
Published: (2009-01-01) -
INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
by: E. I. Alexeeva, et al.
Published: (2015-04-01)